October 20, 2026

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Exploring a 106% Upside Potential Amid Strong Buy Ratings

Xenon Pharmaceuticals Inc. (XENE), a Canadian biotechnology company, is making waves in the healthcare sector with its promising pipeline of neuroscience-focused therapeutics. With a market cap..

Organon & Co. (OGN) Stock Analysis: Evaluating the 24% Return on Equity in a Challenging Healthcare Landscape

Organon & Co. (NYSE: OGN), a stalwart in the healthcare sector specializing in women’s health solutions and biosimilars, offers a compelling yet complex investment narrative. With..

Alvotech (ALVO) Investor Outlook: Analyzing the 43% Potential Upside in the Biosimilar Market

Alvotech (NASDAQ: ALVO) stands at the forefront of the biosimilar medicine market, offering a diverse range of products targeting a spectrum of conditions from autoimmune disorders..

ACADIA Pharmaceuticals Inc. (ACAD): Investor Outlook Reveals 54% Potential Upside Amid Robust Pipeline

For investors seeking opportunities in the biotechnology sector, ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) presents an intriguing prospect with a notable potential upside of 54.17% based on..

Sotera Health Company (SHC) Stock Analysis: Exploring a 28% Potential Upside for Investors

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector with its pivotal role in providing sterilization solutions, lab testing, and advisory services. Operating through..

Hardide tackles erosion challenges in hydraulic fracturing

Hardide's tungsten carbide-based coatings are designed to reduce erosion in oil and gas frac sleeves, helping protect critical surfaces, maintain sealing performance and extend component service..

Genuit Group forecasts £84m operating profit amid challenging markets

Genuit Group reported nine-month revenue of £464.5m, up 3.5% year-on-year on a reported basis, supported by resilience in its Water Division and strong cash conversion above..

Bunzl reports 3.7% underlying revenue growth, reiterates full-year outlook

Bunzl delivered 3.7% underlying revenue growth in the third quarter, supported by volume growth in North America and effective management of inflation...

Plus500 expands into Brazil with acquisition of regulated broker Guru

Plus500 has conditionally agreed to acquire Brazilian broker-dealer Guru, accelerating its expansion across Latin America and providing direct access to the region’s largest economy...

Anglo American maintains 2026 production guidance after resilient Q3 performance

Anglo American reports resilient third-quarter operational performance, with manganese production increasing 6% and steelmaking coal output rising 53% year-on-year. The Group maintains its 2026 production guidance,..

Trifast improves H1 operating margins to 7.4% as UK trading returns to growth

Trifast reports first-half trading in line with market expectations, with underlying EBIT margin improving to 7.4% as UK trading returned to growth and Europe stabilised...

Wickes delivers 4.5% Q3 revenue growth as retail market share gains continue

Wickes Group achieved 4.5% revenue growth in Q3 2026, driven by stronger Retail trading and continued market share gains. Retail revenue increased 6.0%, TradePro sales rose..

James Cropper upgrades full-year profit expectations after strong H1

James Cropper reports a stronger-than-expected first-half performance, driven by revenue growth and cost management in its Paper & Packaging business. The Group now expects full-year adjusted..

Physitrack revenue growth accelerates to 14% in Q3 2026

Physitrack reported 14% year-on-year revenue growth to €3.6m in Q3 2026, its strongest quarterly growth of the year. The company recorded its eighth consecutive quarter of..
Search

Funds

October 20, 2026

Hardide tackles erosion challenges in hydraulic fracturing

Hardide's tungsten carbide-based coatings are designed to reduce erosion in oil and gas frac sleeves, helping protect critical surfaces, maintain sealing performance and extend component service life...

Genuit Group forecasts £84m operating profit amid challenging markets

Genuit Group reported nine-month revenue of £464.5m, up 3.5% year-on-year on a reported basis, supported by resilience in its Water Division and strong cash conversion above 90%...

Bunzl reports 3.7% underlying revenue growth, reiterates full-year outlook

Bunzl delivered 3.7% underlying revenue growth in the third quarter, supported by volume growth in North America and effective management of inflation...

Plus500 expands into Brazil with acquisition of regulated broker Guru

Plus500 has conditionally agreed to acquire Brazilian broker-dealer Guru, accelerating its expansion across Latin America and providing direct access to the region’s largest economy...

Anglo American maintains 2026 production guidance after resilient Q3 performance

Anglo American reports resilient third-quarter operational performance, with manganese production increasing 6% and steelmaking coal output rising 53% year-on-year. The Group maintains its 2026 production guidance, lowers Copper Peru unit cost guidance to approximately 50 cents per pound and raises De Beers production guidance to 25-28 million carats...

Trifast improves H1 operating margins to 7.4% as UK trading returns to growth

Trifast reports first-half trading in line with market expectations, with underlying EBIT margin improving to 7.4% as UK trading returned to growth and Europe stabilised...

Wickes delivers 4.5% Q3 revenue growth as retail market share gains continue

Wickes Group achieved 4.5% revenue growth in Q3 2026, driven by stronger Retail trading and continued market share gains. Retail revenue increased 6.0%, TradePro sales rose 8% and active TradePro members reached 684,000...

James Cropper upgrades full-year profit expectations after strong H1

James Cropper reports a stronger-than-expected first-half performance, driven by revenue growth and cost management in its Paper & Packaging business. The Group now expects full-year adjusted EBITDA of £10.3m to £11.3m, 10-20% ahead of current market expectations of £9.4m...

Physitrack revenue growth accelerates to 14% in Q3 2026

Physitrack reported 14% year-on-year revenue growth to €3.6m in Q3 2026, its strongest quarterly growth of the year. The company recorded its eighth consecutive quarter of positive operating cash flow, while 480 clinics signed up for its new electronic medical record platform ahead of paid subscriptions launching in January 2027...
Search

Funds

October 20, 2026

FTSE 100

Funds